ClinConnect ClinConnect Logo
Search / Trial NCT06304415

Elevated Lipoprotein(a) in Hospital Staff

Launched by CHANGI GENERAL HOSPITAL · Mar 5, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how common high levels of a specific type of cholesterol called lipoprotein(a), or Lp(a), are among hospital staff. Lp(a) is important because having high levels can increase the risk of heart problems. The study aims to understand how many people in the working population, especially those in hospitals, may have elevated Lp(a) levels.

If you're a hospital staff member aged 21 or older, or a family member of someone with high Lp(a), you may be eligible to participate. Participants will be asked to provide some information and possibly undergo tests to check their Lp(a) levels. The study is currently looking for volunteers, and it's a great opportunity to contribute to important research that could help improve heart health in the community.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Any healthcare workers working in healthcare settings (regardless of PHI and/or private setting) aged 21 and above OR family member such as father, mother, siblings, grandparents, spouse and children aged 12 and above of recruited staff with high Lpa ≥120nmol/l
  • 2. Study team members can also be recruited because we are trying to find the prevalence of elevated Lp(a)
  • Exclusion Criteria:
  • 1. Inability to provide informed consent.
  • 2. Pregnant women.
  • 3. Prisoner

About Changi General Hospital

Changi General Hospital (CGH) is a leading tertiary healthcare institution in Singapore, renowned for its commitment to providing high-quality patient care and advancing medical research. As a sponsor of clinical trials, CGH leverages its state-of-the-art facilities and multidisciplinary expertise to facilitate innovative research that aims to enhance treatment options and improve patient outcomes. The hospital is dedicated to upholding rigorous ethical standards and regulatory compliance while fostering collaboration with healthcare professionals and researchers to drive advancements in medical science. Through its clinical trials, CGH seeks to contribute to the global body of knowledge and translate research findings into practical applications for better healthcare delivery.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Trial Officials

Loh Wann Jia

Principal Investigator

Singhealth Foundation

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported